International Patent: TUMOR-SPECIFIC MELITTIN/ANTIBODY DUAL-BLOCKING PRODRUG

GENEVA, Oct. 30 -- SHANGHAI JIAO TONG UNIVERSITY filed a patent application (CN2026/092272) for “TUMOR-SPECIFIC MELITTIN/ANTIBODY DUAL-BLOCKING PRODRUG”. With publication no. WO/2026/223696, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 47/65

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....